The measure would have placed a $1 excise on tobacco products into a protected fund to finance medical research on smoking-related illnesses, strengthen California’s smoking prevention and cessation programs, and enforce the state’s existing tobacco laws.
The independent California Legislative Analyst's Office projected that the measure would have generated approximately $855 million in first year, declining slightly but predictably (about 3% annually due to decrease in the number of smokers) every year thereafter.
[1] The measure would have created a nine-member committee charged with administering direct revenues.
This oversight committee was to be composed of cancer-research medical professionals, University of California Chancellors, and representatives of national disease advocacy groups.
Later, in 2016, the cigarette tax was increased by the successful passage of California Proposition 56.